Binding mode analyses and pharmacophore model development for stilbene derivatives as a novel and competitive class of α-glucosidase inhibitors.

Stilbene urea derivatives as a novel and competitive class of non-glycosidic α-glucosidase inhibitors are effective for the treatment of type II diabetes and obesity. The main purposes of our molecular modeling study are to explore the most suitable binding poses of stilbene derivatives with analyzi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuno Lee, Songmi Kim, Jun Young Kim, Mahreen Arooj, Siu Kim, Swan Hwang, Byeong-Woo Kim, Ki Hun Park, Keun Woo Lee
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d3ce32c651c1477a9d8cc4227adf0de6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d3ce32c651c1477a9d8cc4227adf0de6
record_format dspace
spelling oai:doaj.org-article:d3ce32c651c1477a9d8cc4227adf0de62021-11-18T08:36:57ZBinding mode analyses and pharmacophore model development for stilbene derivatives as a novel and competitive class of α-glucosidase inhibitors.1932-620310.1371/journal.pone.0085827https://doaj.org/article/d3ce32c651c1477a9d8cc4227adf0de62014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24465730/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Stilbene urea derivatives as a novel and competitive class of non-glycosidic α-glucosidase inhibitors are effective for the treatment of type II diabetes and obesity. The main purposes of our molecular modeling study are to explore the most suitable binding poses of stilbene derivatives with analyzing the binding affinity differences and finally to develop a pharmacophore model which would represents critical features responsible for α-glucosidase inhibitory activity. Three-dimensional structure of S. cerevisiae α-glucosidase was built by homology modeling method and the structure was used for the molecular docking study to find out the initial binding mode of compound 12, which is the most highly active one. The initial structure was subjected to molecular dynamics (MD) simulations for protein structure adjustment at compound 12-bound state. Based on the adjusted conformation, the more reasonable binding modes of the stilbene urea derivatives were obtained from molecular docking and MD simulations. The binding mode of the derivatives was validated by correlation analysis between experimental Ki value and interaction energy. Our results revealed that the binding modes of the potent inhibitors were engaged with important hydrogen bond, hydrophobic, and π-interactions. With the validated compound 12-bound structure obtained from combining approach of docking and MD simulation, a proper four featured pharmacophore model was generated. It was also validated by comparison of fit values with the Ki values. Thus, these results will be helpful for understanding the relationship between binding mode and bioactivity and for designing better inhibitors from stilbene derivatives.Yuno LeeSongmi KimJun Young KimMahreen AroojSiu KimSwan HwangByeong-Woo KimKi Hun ParkKeun Woo LeePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 1, p e85827 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yuno Lee
Songmi Kim
Jun Young Kim
Mahreen Arooj
Siu Kim
Swan Hwang
Byeong-Woo Kim
Ki Hun Park
Keun Woo Lee
Binding mode analyses and pharmacophore model development for stilbene derivatives as a novel and competitive class of α-glucosidase inhibitors.
description Stilbene urea derivatives as a novel and competitive class of non-glycosidic α-glucosidase inhibitors are effective for the treatment of type II diabetes and obesity. The main purposes of our molecular modeling study are to explore the most suitable binding poses of stilbene derivatives with analyzing the binding affinity differences and finally to develop a pharmacophore model which would represents critical features responsible for α-glucosidase inhibitory activity. Three-dimensional structure of S. cerevisiae α-glucosidase was built by homology modeling method and the structure was used for the molecular docking study to find out the initial binding mode of compound 12, which is the most highly active one. The initial structure was subjected to molecular dynamics (MD) simulations for protein structure adjustment at compound 12-bound state. Based on the adjusted conformation, the more reasonable binding modes of the stilbene urea derivatives were obtained from molecular docking and MD simulations. The binding mode of the derivatives was validated by correlation analysis between experimental Ki value and interaction energy. Our results revealed that the binding modes of the potent inhibitors were engaged with important hydrogen bond, hydrophobic, and π-interactions. With the validated compound 12-bound structure obtained from combining approach of docking and MD simulation, a proper four featured pharmacophore model was generated. It was also validated by comparison of fit values with the Ki values. Thus, these results will be helpful for understanding the relationship between binding mode and bioactivity and for designing better inhibitors from stilbene derivatives.
format article
author Yuno Lee
Songmi Kim
Jun Young Kim
Mahreen Arooj
Siu Kim
Swan Hwang
Byeong-Woo Kim
Ki Hun Park
Keun Woo Lee
author_facet Yuno Lee
Songmi Kim
Jun Young Kim
Mahreen Arooj
Siu Kim
Swan Hwang
Byeong-Woo Kim
Ki Hun Park
Keun Woo Lee
author_sort Yuno Lee
title Binding mode analyses and pharmacophore model development for stilbene derivatives as a novel and competitive class of α-glucosidase inhibitors.
title_short Binding mode analyses and pharmacophore model development for stilbene derivatives as a novel and competitive class of α-glucosidase inhibitors.
title_full Binding mode analyses and pharmacophore model development for stilbene derivatives as a novel and competitive class of α-glucosidase inhibitors.
title_fullStr Binding mode analyses and pharmacophore model development for stilbene derivatives as a novel and competitive class of α-glucosidase inhibitors.
title_full_unstemmed Binding mode analyses and pharmacophore model development for stilbene derivatives as a novel and competitive class of α-glucosidase inhibitors.
title_sort binding mode analyses and pharmacophore model development for stilbene derivatives as a novel and competitive class of α-glucosidase inhibitors.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/d3ce32c651c1477a9d8cc4227adf0de6
work_keys_str_mv AT yunolee bindingmodeanalysesandpharmacophoremodeldevelopmentforstilbenederivativesasanovelandcompetitiveclassofaglucosidaseinhibitors
AT songmikim bindingmodeanalysesandpharmacophoremodeldevelopmentforstilbenederivativesasanovelandcompetitiveclassofaglucosidaseinhibitors
AT junyoungkim bindingmodeanalysesandpharmacophoremodeldevelopmentforstilbenederivativesasanovelandcompetitiveclassofaglucosidaseinhibitors
AT mahreenarooj bindingmodeanalysesandpharmacophoremodeldevelopmentforstilbenederivativesasanovelandcompetitiveclassofaglucosidaseinhibitors
AT siukim bindingmodeanalysesandpharmacophoremodeldevelopmentforstilbenederivativesasanovelandcompetitiveclassofaglucosidaseinhibitors
AT swanhwang bindingmodeanalysesandpharmacophoremodeldevelopmentforstilbenederivativesasanovelandcompetitiveclassofaglucosidaseinhibitors
AT byeongwookim bindingmodeanalysesandpharmacophoremodeldevelopmentforstilbenederivativesasanovelandcompetitiveclassofaglucosidaseinhibitors
AT kihunpark bindingmodeanalysesandpharmacophoremodeldevelopmentforstilbenederivativesasanovelandcompetitiveclassofaglucosidaseinhibitors
AT keunwoolee bindingmodeanalysesandpharmacophoremodeldevelopmentforstilbenederivativesasanovelandcompetitiveclassofaglucosidaseinhibitors
_version_ 1718421590437265408